| Code | 01656 | ||||||||||
| MA number | 56/0194/00-S | ||||||||||
| Product Form: | plu igf 1x3,75 mg+1xdisp.prostr. (liek.inj.skl.+amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Ipsen Pharma, France | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 19.05.2000 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Diphereline SR 3.75 mg_05_2023.pdf
|
| PIL: |
PIL_Diphereline 3,75 mg_08_2023.pdf
|
| Safety feature | Yes |
| Data update: | 27.09.2019 |
